| Product Code: ETC13312415 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Drug Repurposing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Drug Repurposing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Drug Repurposing Market - Industry Life Cycle |
3.4 North America Drug Repurposing Market - Porter's Five Forces |
3.5 North America Drug Repurposing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.7 North America Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 North America Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 North America Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Drug Repurposing Market Trends |
6 North America Drug Repurposing Market, 2021 - 2031 |
6.1 North America Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Drug Repurposing Market, Revenues & Volume, By On-Target Repurposing, 2021 - 2031 |
6.1.3 North America Drug Repurposing Market, Revenues & Volume, By Off-Target Repurposing, 2021 - 2031 |
6.1.4 North America Drug Repurposing Market, Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031 |
6.1.5 North America Drug Repurposing Market, Revenues & Volume, By Pathway-Based Repurposing, 2020 - 2028 |
6.2 North America Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Drug Repurposing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 North America Drug Repurposing Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.2.4 North America Drug Repurposing Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.5 North America Drug Repurposing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3 North America Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Drug Repurposing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.3.3 North America Drug Repurposing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.3.4 North America Drug Repurposing Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.3.5 North America Drug Repurposing Market, Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031 |
6.4 North America Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.2 North America Drug Repurposing Market, Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031 |
6.4.3 North America Drug Repurposing Market, Revenues & Volume, By High-Throughput Screening, 2021 - 2031 |
6.4.4 North America Drug Repurposing Market, Revenues & Volume, By Biomarker-Based Repurposing, 2020 - 2028 |
6.4.5 North America Drug Repurposing Market, Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2020 - 2028 |
7 North America Drug Repurposing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.1 United States (US) Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.2 Canada Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.3 Rest of North America Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.3 North America Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
7.3.1 United States (US) Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.2 Canada Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.3 Rest of North America Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.4 North America Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United States (US) Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Canada Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Rest of North America Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 North America Drug Repurposing Market Key Performance Indicators |
9 North America Drug Repurposing Market - Export/Import By Countries Assessment |
10 North America Drug Repurposing Market - Opportunity Assessment |
10.1 North America Drug Repurposing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
10.3 North America Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
10.4 North America Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 North America Drug Repurposing Market - Competitive Landscape |
11.1 North America Drug Repurposing Market Revenue Share, By Companies, 2022 |
11.2 North America Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here